utritional deficiencies in children with Attention Deficit/Hyperactivity Disorder: A focus on amino acids - Nutrients and ADHD.

Ansynth Service B.V.0 个研究点目标入组 187 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

Trial is onging in other countries

•For both groups (the clinical group that consists of children with ADHD and the reference group) the inclusion criteria are that children are (a) between 6 and 13 years old and (b) in grade 1 to 6 from elementary school. Children in the clinical group have received a clinical diagnosis of ADHD, confirmed by standardized assessments.

•There is one exclusion criterion for the clinical group and that is that children will not be able to participate when they use methylphenidate (MPH) during the testing. The behaviour and functioning of children should not be influenced by medication when they will be assessed. Children who are receiving a psychopharmacological treatment for ADHD could discontinue their treatment for a short period in order to be able to participate. After the discontinuation of stimulant use, a complete washout will be achieved within 48 hours (Pelham et al., 1999). Therefore, the medication break could be limited to five days (two days before the testing period and three days of testing). Stimulant medication is often discontinued (initiated by parents) during weekends or school-holidays in order to limit the consequences of the negative side effects associated with the use of MPH. The decision for a medication break of five days will be taken in consultation with the responsible psychiatrist of the child.
•There will be no exclusion criteria for comorbid disorders that frequently co-occur with ADHD, such as oppositional defiant disorder (ODD), conduct disorder (CD), autism spectrum disorder (ASD) or learning disorders. Using these exclusion criteria would decrease the probability of having a representative sample.

发起方

Ansynth Service B.V.